Indianapolis, Indiana — According to state and local economic development sources POINT Biopharma plans to invest $25,000,000.00 to build out 77,000 square feet of new space in Indianapolis. The company plans to occupy the new space at 4850 W. 78th St in Indianapolis, on or about December 1, 2020. According to the company website POINT Biopharma is a novel, research based biotechnology company focused on the development and commercialization of radiopharmaceutical products to meet unmet patient needs.

To learn more about POINT Biopharma, visit http://www.pointbiopharma.com/

Company Contact:
Joe McCann, Chief Executive Officer
https://www.linkedin.com/in/joe-mccann-5a9b6bb/
289-444-0178

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved